Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Exploring the view of Ocular Pharmacology and Eye Care, Therapeutics and Drug delivery
- Ocular Pharmacology & Eye Care

About

Allied Academic Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

Target to Audience:
 
Ophthalmologist
Pharmacologists
Pharmacists
Ocular surgeons
Students
Clinical Pharmacist
General Practitioners
Researchers
University Professors
Delegates
Attendees

Why to Attend Ocular Pharmacology and Eye Care 2017???

Ocular Pharmacology and Eye Care 2017 offers the best and propelled advances in the field of ophthalmology. With individuals from around the globe concentrated on finding out about Ophthalmologists; this is your best chance to achieve the biggest array of members from the Ophthalmologists and Pharmacologists people group, ophthalmology society, European pharmacology gatherings, American ophthalmology society. Direct presentations, disseminate data, meet with present and potential researchers, make a sprinkle with new medication improvements, and get name acknowledgment at this 2-day occasion. Widely acclaimed speakers, the latest methods, improvements, and the most current upgrades in Ophthalmology are signs of this gathering.

Ocular Pharmacology and Eye Care 2017 meeting will unite an energizing equalization of industry and the scholarly community, so appoints have the one of a kind chance to connect with associates from various parts and talk about new research in diagnostics, retinal pharmacology, ophthalmic drug delivery, ocular therapeutics.

The conference creates a platform to interact with members related to the field of Ophthalmology and pharmacology to discuss and pave ways for novel research.

Conference Opportunities

 For Researchers and Faculty Members:

 Speaker Presentations

 Poster Display

 Symposium hosting (4-5 member team)

 Workshop organizing

 For Universities, Associations & Societies:

 Association Partnering

 Collaboration proposals

 Academic Partnering

 Group Participation

For Students and Research Scholars:

 Poster Competition (Winner will get Best Poster Award)

 Young Researcher Forum (YRF Award to the best presenter)

 Student Attendee

 Group registrations

 For Business Delegates:

 Speaker Presentations

 Symposium hosting

 Book Launch event

 Networking opportunities

 Audience participation

 For Product Manufacturers:

 Exhibitor and Vendor booths

 Sponsorships opportunities

 Product launch

 Workshop organizing

 Scientific Partnering

 Marketing and Networking with clients 

 

Welcome Message

We are delight to invite you a new initiative, "18th International Conference on Ocular Pharmacology and Eye Care” going to be held in Rome, Italy
 
Allied Academies Meetings invites you to go to Conference on Ocular Pharmacology and Eye Care held in Rome, Italy, December 4-5,2017 with the theme, "Exploring the view of Ocular Pharmacology and Eye Care, Therapeutics and Drug delivery” This international meet (Ocular Pharmacology and Eye Care 2017) foresees several delegates including keynote speakers, Oral presentations by prestigious speakers and publication presentations by understudies other than representatives around the globe. This gathering maybe a mammoth occasion that makes a perfect stage to share aptitude tending to current advancements required in Ocular Pharmacology and Eye Care. It will be an awesome open door for every one of the representatives as it gives a universal systems administration chance to team up with the world class Experts of Ophthalmology and pharmaceutical field.

Ocular Pharmacology and Eye Care is a subspecialty of ophthalmology providing basic and clinical research about biopharmaceuticals and other modalities that have the potential to prevent, treat, and/or diagnose ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders.

Ocular Pharmacology and Eye Care 2017 conference follows the theme “Exploring the view of Ocular Pharmacology, Therapeutics and Drug delivery” to discuss about the various ways to use the right drug during the treatment.

Session/Tracks

Ocular Physiology:                            

Eye is a sensory organ. Sensory organ is an organ that contains sensory receptors and accessory structures, that contributes to the sensory function of the receptor, included in the sensory organ. In the case of eye, the sensory part is the retina which contains photoreceptors, bipolar, horizontal, amacrine, and ganglionic cells. The other structures of the eye contribute to the function of the eye (vision).

The physiology of the eye, it is an obligatory step to study its structure, because structure- function interrelationship is inseparable .Our approach in studying ocular physiology in this course will be by studying the function of each part of the eye and the function, fulfilled by that structure. The eye ball is composed of three layers (Sclera, cornea, choroid, uvula, and retina) and three transparent media (two chambers of aqueous humour, and vitreous humour). Externally, the eye is protected by eyelids, eye lashes, and eye brows .It is found in the orbit of the skull, and this is an additional protective factor as thus is surrounded by bones.

·         Anatomy of the Eye

·         Refractive power of the eye

·         Physiology of the vitreous Humor

·         Tears Physiology

·         Ocular Adnexa

·         Routes of Administration into the Eye

Ocular Surface Pharmacology:

Ocular Pharmacology includes the both pharmacodynamics and pharmacokinetics of the ocular drug to be administered. Biological and therapeutic effect of the drug, that is Mechanism of Action. Most drugs act by binding to regulatory macromolecules, usually neurotransmitters or hormone receptors or enzymes. If the drug is working at the receptor level, it can be agonist or antagonist. If the drug is working at the enzyme level, it can be activator or inhibitor. Absorption, distribution, metabolism, and excretion of the drug comes under pharmacokinetics. A drug can be delivered to ocular tissue as locally (Eye drop, Ointment, Peri ocular injection, Intraocular injection), Systemically(Orally, IV). The factors that influence local drug penetration into ocular tissue are 1. Drug concentration and solubility shows higher the concentration the better the penetration. (pilocarpine 1?4% but limited by reflex tearing) 2.Viscosity: Addition of methylcellulose and polyvinyl alcohol increases drug penetration by increasing the contact time with the cornea and altering corneal epithelium 3.Lipid solubility: because of the lipid rich environment of the epithelial cell membranes, the higher lipid solubility the more the penetration, surfactants, pH, drug tonicity, molecular weight and size. 

·         Glaucoma and its advanced and intregrated treatments

·         Ocular pharmacotherapy/clinical trials

·         Ocular drug delivery and biotransformation

·         Ocular ischemia and blood flow

·         Ocular inflammatory and immune disorders

Immunology and ocular infection:

Ocular immunology is a profoundly concentrated branch of solution committed to diagnosing and treating patients with incendiary eye sicknesses. These infections can somewhat diminish vision or prompt extreme vision loss (Blindness). Countless contaminations, minute living beings, parasites, and developments that can assault the human body are furthermore prepared for striking the surface or within the eye. The general slant for immunologic disease to impact the eye gets from different parts, for instance, Antibody-subordinate and immunizer mediated contaminations, Uveitis, intraocular disturbance and cell-intervened disorders.

Ophthalmologists utilize the general term, uveitis, when alluding to the scope of incendiary maladies that influence the uvea. The inside of the eye needs lymph vessels yet is very vascularized, and numerous insusceptible cells live in the uvea, including for the most part macrophages, dendritic cells, and pole cells. These cells battle off intraocular contaminations, and intraocular aggravation can show as uveitis or retinitis. The cornea of the eye is immunologically an extremely extraordinary tissue. Likewise, uveitis is utilized to portray any provocative infection that produces swelling and demolishes eye tissues, including inside the retina. It's normally connected with systemic infections, for example, rheumatoid joint inflammation.

·         Antibody-dependent & Antibody-mediated Diseases

·         Cell-mediated Diseases

·         Microbial flora of normal eye both aerobic and anaerobic

·         Fungal Endophthalmitis

·         Corneal graft reactions

·         Recent developments in Immunotherapy

Retinal pharmacology:

Pharmacology of GABA receptors of retinal dopaminergic neurons. When the vertebrate retina is empowered by light, a class of interplexiform cells discharge dopamine, a modulator in charge of neural adjustment to light. In the in place retina, dopamine discharge can be pharmacologically controlled with agonists and adversaries at GABA receptors, and dopaminergic cells get contribution from GABA ergic amacrines. GABA is the principle inhibitory neurotransmitter in the vertebrate CNS.

·         Neuro pharmacological retinal experiments

·         Electrophysiology comprising field potentials

·         Physico-chemical parameters and on drug actions

·         Endogenous and exogenous neuroprotectors for retina

Retinal disorders:

Retina is a part of CNS. It is a straightforward thin layer of tissue that lines back of eye and sends visual messages through optic nerve to the mind. Light striking the retina starts a course of compound and electrical occasions that at last trigger nerve driving forces .Macula situated in the focal point of retina contains high thickness of photoreceptors which gives sharp and focal vision. Retinal issue may influence the imperative tissue macula which may influence the vision which may some of the time cause genuine visual impairment.

It contains a substantial number of light-sensitive cells and other nerve cells that get and form visual information. Your retina sends this information to your cerebrum through your optic nerve, enabling you to see. Retinal degenerative issue, for instance, Age-related macular degeneration and partially blind macular degeneration affecting energetic and old from various social orders, races and ethnicities. The central zone of the retina contains a high thickness of shading fragile photoreceptor cells called cones which are accountable for shading vision and in this way any distortion and change in the central domain of the retina will provoke colour vision defects. On the other hand illnesses like Diabetic retinopathy and Retinal tumours can moreover be accountable for the enduring vision disaster if it is not treated on time.

·         Retinal tears and Detachment

·         Age Related Macular Degeneration (ARMD)

·         Cancers Affecting Retina

·         Retinoblastoma

·         Cone-Rod Dystrophy

·         Diabetic Retinopathy

Ocular Diagnosis and Ophthalmic Imaging:

Eye offers an excellent open door for cutting edge imaging innovation to screen and study eye and systemic diseases. These strategies keep on gaining tremendous significance in the assessment of visual and orbital infection as specialized improvements and refinements are made. This concentrates in giving information on various demonstrative and imaging instruments that are used, the latest progressions and the novel frameworks that are taken after to enhance the finding and restorative imaging of various visual sicknesses.

In the previous decade, the appearance of ultrasonography, registered tomography, and all the more as of late attractive reverberation imaging has given symptomatic pictures of the eye, circle, and mind in a manner that had been a fantasy of numerous before the development of these systems. These newer modes of diagnosis have replaced some previous techniques, such as nuclear medicine imaging and, to some degree, vascular studies and orbitography.

·         Tear Film Stability Tests

·         Tear Volume Tests

·         Tear Prism Height Test

·         Stain Tests

·         Hyperosmolarity tests

·         Angiography

·         Electro Retinography

·         Optical coherence tomography

·         Pachymetry

·         Ultrasonography

Ocular pharmacotherapy:

Ocular Pharmacotherapy concerns the utilization of medications to treat maladies of the eye. One of the principles of pharmacotherapy is to maximize the amount of drug that reaches the site of action in a sufficient concentration to cause a beneficial therapeutic effect.

·         Lipid Based Nanocarriers

·         Carbonic anhydrase inhibitors

·         Ocular nanomedicines

·         Novel Drugs

·         Ophthalmic Drug Delivery System

·         NMDA antagonists

·         Surgical implant

·         Punctal Plug

·         Ophthalmic inserts

Ocular diseases:

Eye is an exceedingly delicate and vascularised complex structure there are many possibilities for maladies which don't have any early indications and are effortless. So best resistance is to have standard check-up, since eye maladies don't generally have indications. Early location and treatment could avert vision misfortune.

An Ocular indication of a systemic infection is an eye condition that by implication comes because of a malady procedure. Diabetes, is the main source of new instances of visual impairment in those matured 20–74, with visual indications, for example, diabetic retinopathy and macular edema influencing most of the individuals who had the ailment for a long time or more. Different maladies, for example hypertension are usually found to have related visual manifestations.

·         Glaucoma

·         Conjuctivitis

·         Optic Neuritis

·         Sarcoidosis

·         Macular degeneration

·         Refractive Errors

·         Ocular ischemia

·          Keratoconous

·         Anterior Eye Segment Disorders

     ·    Thyroid eye Disease   

     ·       Ocular malformation

      ·       Presbyopia

       ·         Nearsightedness

       ·         Farsightedness

       ·         Astigmatism

     ·      Ocular Hypotension

      ·         Primary Open Angle glaucoma

      ·         Closed Angle glaucoma

     ·         Ocular Tuberculosis

 Genetical Disorders of Eye:

Scientists have mapped a few qualities for glaucoma and are beginning to distinguish responsible genes in macular degeneration. They likewise are gaining extremely critical ground in distinguishing the qualities that cause retinitis pigmentosa, a degenerative malady of the retina that causes night visual impairment and slow vision misfortune. In adults, glaucoma and age-related macular degeneration are two of the main sources of visual deficiency. Blindness among new-born are brought about by acquired eye ailments, for example, innate glaucoma, retinal degeneration, optic decay and eye distortions. Patients with specific sorts of strabismus have a family history of the sickness and endeavours are presently under approach to distinguish the responsible genes.

·         Amblyopia

·         Cataracts

·         Color Blindness

·         Congenital Eye Defect

·         Diabetic Retinopathy

·         German Measles

·         Ocular Cancer

·         Night Blindness

·         Retinitis Pigmentosa

Pharmacology of ocular drugs:

Pharmacology of visual medications is the review and use of pharmaceuticals to both break down and treat sicknesses of the eye. There are distinctive microbial illnesses of the eye like viral, steroids, Fungal pollutants of the cornea, which are remarkable yet may occur after agrarian injuries or in hot and soggy climates, orbital mycosis is even rarer, and generally occurs after spread from the Para nasal sinuses. Growing age, debility, or immunosuppression enhances likelihood and reality of sickness. Herpes simplex ailments conveying, for example, dendritic corneal ulcers can be treated with acyclovir.

Pharmacology manages with increase in efficiency, safety and rationality of drug use and discovery of new medications. Specificity pharmacology describes mechanism of action of drugs, distinguish the destiny of medications in the body (ADME), scan for new medications. Pharmacology looks at the earliest preclinical pharmaceuticals for instance animal (trial or experimental pharmacology), later in humans (clinical pharmacology). By studying the toxic effects of medications is occupied with toxicology.

·         Anesthetics

·         Anti Biotics

·         Anti-infectives/Antifungals/Antivirals

·         Antihistamines

·         Non-steroidal anti-inflammatory eye medications

·         Ophthalmic Steroids

·         Beta Blockers

·         Immunomodulators

·         Mast Cell Stabilizers

·         Ocular Decongestants/Vasoconstrictors

·         Prostaglandin Agonists

Ophthalmic Drug Delivery:

Ophthalmic medication conveyance is a standout among the most difficult and interesting endeavor to define without creating any tissue harm to the defensive obstructions of eye. Most normal ophthalmic arrangements are accessible as eye drops, arrangements, treatments which now a days are novel ophthalmic medication conveyance frameworks turned out to combat the present destructive diseases.

Ophthalmic medication conveyance frameworks are currently getting expanded consideration, to some extent due to the normal rise of new medications with short organic half-experience whose convenience may rely on upon a more persistent medication supply than eye drops can give, additionally in light of the capability of some conveyance frameworks to decrease the symptoms of the more powerful medications. The utilization of medication stacked contact focal points and visual additions enables medications to be better set where they are required for more straightforward conveyance. Advancements in visual inserts give a way to defeat the physical boundaries that generally counteracted successful treatment. Embed advances are a work in progress permitting long haul medicate conveyance from a solitary strategy, these gadgets enable back chamber sicknesses to be successfully treated. Future improvements could bring fake corneas to take out the requirement for contributor tissue and erratic implantable medication warehouses enduring the patient's lifetime.

Conventional- suspension, balm, gels, Vesicular - Liposomes, niosomes, pharmacosomes, Pariculate-Micropartles, Nanoparticles/Nano spheres, Control discharge Implants, hydrogel Contact lenses, Hydrogels, micro needle, micro emulsion. Advanced-collagen shields, visual inserts (erodible, nonedible), gene conveyance, immature microorganism.

·         Topical administration

·         Systemic (Parenteral) Administration

·         Oral Administration

·         Periocular and Intravitreal Administration

·         Pharmacokinetics and sustained drug delivery

Pharmacology of Ocular Therapeutics:

Principle ranges of pharmacology of ocular therapeutics are pharmacodynamics and pharmacokinetics .It is challenging to obtain drug concentrations at the target site, ocular pharmacokinetics, and thus pharmacokinetic-pharmacodynamic interactions, are rarely available. Pharmacodynamics concentrates the impacts of a medication on organic frameworks, and Pharmacokinetics concentrates the impacts of natural frameworks on a medication. In wide terms, pharmacodynamics talks about the chemicals with natural receptors, and pharmacokinetics examines the ingestion, appropriation, digestion, and discharge (ADME) of chemicals from the organic frameworks. Ocular pharmacokinetics, concerned with the ocular compartments, which comprise tear film and cul-de-sac, anterior chamber, vitreous cavity and retro or periocular space.\

·         Opportunities for the Development of Newer Drugs for Ocular Use

·         Drug Transport Across Blood-Ocular Barriers and Pharmacokinetics

·         Pharmacogenomics of Drugs in Ocular Therapeutics

·         Steroidal and Nonsteroidal Anti-inflammatory Agents for Ocular Use

·         Chemotherapy for Ocular Cancers

·         Utility of intravital microscopy for ocular disease

·         RNA-directed therapies for retinal diseases

·         New advances in ocular drug delivery

·         New Treatments in Diabetic Retinopathy

Advancements in Ocular Therapeutics:

The foundation of fruitful high quality ophthalmology depends on watchful and basic examination of the eye. Recent advances in visual therapeutics incorporate the chemotherapy of visual contaminations and visual aggravations, demonstrative and restorative medications in strabismus, toxicology, anaesthesia, the medicinal treatment of glaucoma, visual tumours, retinal vascular illnesses, myasthenia gravis, dry eye, optic neuritis and healthful amblyopia, and some corneal conditions.

·         New ophthalmic uses for existing drugs

·         New strategies for neuroprotection and regeneration in glaucoma

·         New treatments for retinal disease

·         Novel drugs and devices for IOP lowering

·         Pharmacokinetics and sustained drug delivery

·         Biomarker Therapy for Regeneration

Clinical meets pre-clinical: Translational Research:

The pre-clinical headway of a potential remedial specialist includes the assembling and formal testing of ADMET properties in arrangement for accommodation to an administrative organization for human trials. Thorough adequacy investigations of a pre-clinical lead hopeful may likewise be led. These procedures require administrative mastery in their plan, Good Manufacturing Practise (GMP) assembling, and good Laboratory practise (GLP) toxicology examines and additionally thought of future clinical trial outline. Result of creature models is essential to connect the translational crevice to the facility.

·         3-D Anterior Segment Imaging

·         Biomarker/Gene Expression Pilot Study

·         Genes in Diabetic Retinopathy

·         OCT-Opthalmoscope

·         Collaborative Ocular Melanoma

·         Vision care Implantable Miniature Telescope

·         Wet AMD Eyedrop Treatment

Pharmaceutical and Regulatory Aspects of Ocular Drug Administration:

Ophthalmology Novel Research:

Ocular Toxicology:

Visual Toxicology focuses on undesirable symptoms on eye brought about because of different medications. Particularly in youngsters Glaucoma and waterfall actuated because of utilization of corticosteroids. Chloroquine may bring about retinopathy, heart piece and swirl keratopathy. Steroids, sulphonamides may bring about transient myopia. Tearing of lacrimal framework created by antihypertensive. Diminished focal vision reaction of thioridazine.

Vision Strategy:

Too many eyes and not enough time – delivering eye care to the nation.

·         Dry eye and blepharitis management

·         Eye drop work shop

·         Gonioscopy

·         Interpretaion of OCT cases

·         Management of dry eye

·         Ocular allergy

·         Ocular first aid

·         Red eye work shop

·         Life at the receiving end referrals into ophthalmology

·         Vitamin D Deficiency and its relevance to eye health

·         Glaucoma treatment –what you need to know in primary car

·         Blinking eyelids

·         Giving nutritional advice to support eye health

Public Health & Integrated Eye Care:

This program gives ophthalmic experts the learning and abilities required to reduce blindness and visual disability in their populations by developing an evidence-based public health approach for the control and management of blinding eye ilnesses. It empowers students to contribute effectively at a local, national and international level in research, training and benefit conveyance.

This will empower students to build-up a public health oriented approach to eye care services and the control of visual deficiency with regards to the targets objectives of Vision 2017: The Right to Sight.

·         Delays to follow-up eye appointments

·         Optician practices and local hospital eye services

·         Networked opthamology care

·         National eye health week

·         Funding eye reasearch

·         Reducing vision-related fields

·         Community eye health

·         Using patient experience to improve eye care services

·         Sight loss and mental health

OCT Angiography:

Oculoplastic and Reconstructive Surgery:

Oculoplastic surgery includes wide range of sorts of eyelid and facial surgery, going from basic eyelid malposition’s to more perplexing reproduction including the eyelids and encompassing temple, fleeting and cheek zones. They comprehend the fragile life structures and capacity of the eyelids and their encompassing structures. And also the eyelids, they have practical experience in the lacrimal (tear) framework, the circle (bone cavity around the eye), contiguous peri-ocular and facial structures.

Ocular Oncology( Ocular Tumours):

Eye care: Career, Training, Courses, Education and Management :


To Collaborate Scientific Professionals around the World

Conference Date December 4-5, 2017
Speaker Oppurtunity
Venue
&
Hospitality

Holiday Inn Rome Aurelia , Via Aurelia Km 8,400, 00165 Rome,Italy.

December 4-5,2017

Join The Discussion

Contact Desk

Program Enquiry

Drop us an email for Program enquiry.

ocularpharmacology2017@rediffmail.com

+1 201-877-9344

Sponsors

Sponsors / Exhibiting / Advertising.

ocularpharmacology@protonmail.com

+1 201-877-9344

General Queries

Program director

ocularpharmacology2017@rediffmail.com

+1 201-877-9344

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
Media Partners
Copyright © 2017-2018 Allied Academies, All Rights Reserved.